128 related articles for article (PubMed ID: 28941130)
1. Quality of life as a prognostic factor for survival in hepatocellular carcinoma.
Sternby Eilard M; Hagström H; Mortensen KE; Wilsgaard T; Vagnildhaug OM; Dajani O; Stål P; Rizell M
Liver Int; 2018 May; 38(5):885-894. PubMed ID: 28941130
[TBL] [Abstract][Full Text] [Related]
2. The association of liver function and quality of life of patients with liver cancer.
Li L; Mo F; Hui EP; Chan SL; Koh J; Tang NLS; Yu SCH; Yeo W
BMC Gastroenterol; 2019 May; 19(1):66. PubMed ID: 31046687
[TBL] [Abstract][Full Text] [Related]
3. Prognostic values of EORTC QLQ-C30 and QLQ-HCC18 index-scores in patients with hepatocellular carcinoma - clinical application of health-related quality-of-life data.
Li L; Mo FK; Chan SL; Hui EP; Tang NS; Koh J; Leung LK; Poon AN; Hui J; Chu CM; Lee KF; Ma BB; Lai PB; Chan AT; Yu SC; Yeo W
BMC Cancer; 2017 Jan; 17(1):8. PubMed ID: 28052758
[TBL] [Abstract][Full Text] [Related]
4. Status of inflammation in relation to health related quality of life in hepatocellular carcinoma patients.
Li L; Chan SL; Mo F; Hui EP; Koh J; Chan AK; Tang NL; Chu CM; Hui J; Lee KF; Yu S; Yeo W
Qual Life Res; 2019 Sep; 28(9):2597-2607. PubMed ID: 31037590
[TBL] [Abstract][Full Text] [Related]
5. The added value of quality of life (QoL) for prognosis of overall survival in patients with palliative hepatocellular carcinoma.
Diouf M; Filleron T; Barbare JC; Fin L; Picard C; Bouché O; Dahan L; Paoletti X; Bonnetain F
J Hepatol; 2013 Mar; 58(3):509-21. PubMed ID: 23178978
[TBL] [Abstract][Full Text] [Related]
6. Psychometric validation of the EORTC QLQ-HCC18 in patients with previously treated unresectable hepatocellular carcinoma.
Serrano D; Podger L; Barnes G; Song J; Tang B
Qual Life Res; 2022 Mar; 31(3):937-950. PubMed ID: 34518988
[TBL] [Abstract][Full Text] [Related]
7. A Prospective Evaluation of the Reliability and Utility of Quality of Life Measures in Patients With Hepatocellular Carcinoma.
Kim GA; Kim HI; Chang S; An J; Lee D; Lee HC; Han S; Shim JH
Am J Clin Oncol; 2019 Jul; 42(7):555-563. PubMed ID: 31135382
[TBL] [Abstract][Full Text] [Related]
8. Optimal cut points for quality of life questionnaire-core 30 (QLQ-C30) scales: utility for clinical trials and updates of prognostic systems in advanced hepatocellular carcinoma.
Diouf M; Bonnetain F; Barbare JC; Bouché O; Dahan L; Paoletti X; Filleron T
Oncologist; 2015 Jan; 20(1):62-71. PubMed ID: 25542450
[TBL] [Abstract][Full Text] [Related]
9. Development of a questionnaire module to supplement the EORTC QLQ-C30 to assess quality of life in patients with hepatocellular carcinoma, the EORTC QLQ-HCC18.
Blazeby JM; Currie E; Zee BC; Chie WC; Poon RT; Garden OJ;
Eur J Cancer; 2004 Nov; 40(16):2439-44. PubMed ID: 15519517
[TBL] [Abstract][Full Text] [Related]
10. Correlations of health-related quality of life with serum inflammatory indicators IL-8 and mIBI in patients with hepatocellular carcinoma.
Li L; Chan SL; Mo F; Hui EP; Koh J; Chan AKC; Tang NLS; Lee KF; Lai PBS; Yu SCH; Yeo W
Cancer Manag Res; 2019; 11():2719-2727. PubMed ID: 31040713
[TBL] [Abstract][Full Text] [Related]
11. Prospective Longitudinal Assessment of Quality of Life for Liver Cancer Patients Treated With Stereotactic Body Radiation Therapy.
Klein J; Dawson LA; Jiang H; Kim J; Dinniwell R; Brierley J; Wong R; Lockwood G; Ringash J
Int J Radiat Oncol Biol Phys; 2015 Sep; 93(1):16-25. PubMed ID: 26279020
[TBL] [Abstract][Full Text] [Related]
12. Quality of life as a prognostic factor of overall survival in patients with advanced hepatocellular carcinoma: results from two French clinical trials.
Bonnetain F; Paoletti X; Collette S; Doffoel M; Bouché O; Raoul JL; Rougier P; Masskouri F; Barbare JC; Bedenne L
Qual Life Res; 2008 Aug; 17(6):831-43. PubMed ID: 18618292
[TBL] [Abstract][Full Text] [Related]
13. Role functioning is associated with survival in patients with hepatocellular carcinoma.
Meier A; Yopp A; Mok H; Kandunoori P; Tiro J; Singal AG
Qual Life Res; 2015 Jul; 24(7):1669-75. PubMed ID: 25502092
[TBL] [Abstract][Full Text] [Related]
14. Health-related quality-of-life impact of pembrolizumab versus best supportive care in previously systemically treated patients with advanced hepatocellular carcinoma: KEYNOTE-240.
Ryoo BY; Merle P; Kulkarni AS; Cheng AL; Bouattour M; Lim HY; Breder V; Edeline J; Chao Y; Ogasawara S; Yau T; Garrido M; Chan SL; Daniele B; Norquist JM; Chen E; Siegel AB; Zhu AX; Finn RS; Kudo M
Cancer; 2021 Mar; 127(6):865-874. PubMed ID: 33231873
[TBL] [Abstract][Full Text] [Related]
15. Quality of life is predictive of survival in patients with unresectable hepatocellular carcinoma.
Yeo W; Mo FK; Koh J; Chan AT; Leung T; Hui P; Chan L; Tang A; Lee JJ; Mok TS; Lai PB; Johnson PJ; Zee B
Ann Oncol; 2006 Jul; 17(7):1083-9. PubMed ID: 16600982
[TBL] [Abstract][Full Text] [Related]
16. Development of a prognostic scoring system for resectable hepatocellular carcinoma.
Sposito C; Di Sandro S; Brunero F; Buscemi V; Battiston C; Lauterio A; Bongini M; De Carlis L; Mazzaferro V
World J Gastroenterol; 2016 Sep; 22(36):8194-202. PubMed ID: 27688661
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of combined preoperative prognostic nutritional index and body mass index in HCC after hepatectomy.
Ji F; Liang Y; Fu S; Chen D; Cai X; Li S; Peng B; Liang L; Hua Y
HPB (Oxford); 2017 Aug; 19(8):695-705. PubMed ID: 28479010
[TBL] [Abstract][Full Text] [Related]
18. The prognostic value of WHO performance status in relation to quality of life in advanced colorectal cancer patients.
Mol L; Ottevanger PB; Koopman M; Punt CJ
Eur J Cancer; 2016 Oct; 66():138-43. PubMed ID: 27573427
[TBL] [Abstract][Full Text] [Related]
19. Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials.
Quinten C; Coens C; Mauer M; Comte S; Sprangers MA; Cleeland C; Osoba D; Bjordal K; Bottomley A;
Lancet Oncol; 2009 Sep; 10(9):865-71. PubMed ID: 19695956
[TBL] [Abstract][Full Text] [Related]
20. Health-related quality of life in early breast cancer.
Groenvold M
Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
